| Document Date: 2011-02-07 14:02:08
Open Document File Size: 551,15 KBShare Result on Facebook
City Bethesda / OCI / / Company Engineering Laboratory / ABC / / Country United States / / / Event Product Issues / / Facility National Cancer Institute / / IndustryTerm shRNA cloning site / online version / / MedicalCondition cancers / tumor / M. Q. MALT lymphoma / diffuse large-B-cell lymphoma / cancer / Lymphoma / lymphoma cell lines / B cell lymphoma / primary tumours / B cell lymphoma cells / diffuse large B-cell lymphoma / tumour / classical Hodgkin lymphoma / each retroviral infection / Hodgkin lymphoma / mediastinal large B-cell lymphoma / lymphoma cells / only certain cancer / MALT lymphoma / infection / lymphoma type / diffuse large B-cell lymphomas / deficiency / cancer Vu N. Ngo1 / TETR-expressing lymphoma cells / B-cell lymphoma / gastric mucosa associated lymphoid tissue lymphoma / genes controlling cancer / derived cancer / / MedicalTreatment chemotherapy / / Organization National Cancer Institute / National Institute of Health / Center for Cancer Research / / Position Author Information The / respective messenger / representative / reporter / IkBa luciferase reporter / / Product doxycycline / function / development / / ProvinceOrState Maryland / / PublishedMedium Cancer Research / / Technology bar code / DNA Chip / siRNA / gene expression / chemotherapy / http / cloning / apoptosis / / URL www.nature.com/nature / www.ncbi.nlm.nih.gov/geo / /
SocialTag |
doi:[removed]nature04687 LETTERS A loss-of-function RNA interference screen for molecular targets in cancer Vu N. Ngo1*, R. Eric Davis1*, Laurence Lamy1, Xin Yu1, Hong Zhao1, Georg Lenz1, Lloyd T. Lam1, Sandeep Dave1,